Search
Sumario de resultados
TIpos de contenido
Fecha
-
CompanyMELIUS ORGANICS
-
NewGENESIS Biomed holds its 2025 Annual Symposium at the Parc Científic de Barcelona
The event featured the intervention of Josep Lluís Falcó, CEO of the company, who addressed the trends and challenges of the sector; Andreu M. Climent, CEO of CORIFY, as a success story of a start-up
-
NewAn Innovative App developed at San Cecilio Clinical Hospital with Support from ibs.GRANADA...
Manos Seguras 3.0, designed in collaboration with a Granada-based startup and supported by ibs.GRANADA, boosts the prevention of healthcare-associated infections
-
NewaptaTargets transferred ApTOLL to Merck
ApTOLL completed a Phase 1b/2 clinical trial for acute ischemic stroke with positive results. Merck to assume clinical development and commercialization of ApTOLL.
-
-
NewKadans becomes a new member of the Spanish Association of Science and Technology Parks
Kadans Science Partner, a European leader in innovation campus development, has joined the Association of Science and Technology Parks of Spain (APTE) as an affiliate member. With operations across
-
NewALLOX, the startup exploring allosterism to revolutionize drug development
Recently established at the Barcelona Science Park, ALLOX is harnessing cutting-edge technology that merges genetics, artificial intelligence, and energy modeling to explore allosterism — a crucial
-
NewCase study: Development of the new GMP plant of 53Biologics
53Biologics strengthens its biopharmaceutical capacity in Spain with a new GMP facility in Valladolid, designed in collaboration with Klinea to meet the highest standards and optimize the production
-
NewRepronovo raises $65 million Series A financing to advance phase 2 clinical trials of nove...
Round led by Jeito Capital, co-led by AXA IM Alts and M Ventures, with strong syndicate support from Ysios Capital and ALSA Ventures
-
NewGate2Brain secures over €700,000 in CDTI Multipaís funding to advance a novel therapy ag...
Gate2Brain secures key funding to advance its groundbreaking pediatric brain tumor therapy
-
NewInternational Clinical Trials Day: Driving healthcare innovation through Artificial Intell...
The TerminAI project aims to optimize healthcare data management through artificial intelligence, enhancing the efficiency and accuracy of clinical information coding.
-
Press releaseInternational Clinical Trials Day: Driving healthcare innovation through Artificial Intell...
Spain positions itself as a European leader in clinical trials, while facing challenges such as improving clinical data coding and increasing investment in R&D. The TerminAI project aims to optimize
-
CompanyBIODURO
-
-
CompanyDISRUPT THERAPEUTICS
-
New#NewAseBioMember | “AseBio is the meeting point for all companies that aim to contribute t...
Meet our new member MedBioinformatics. We sponke with Patricia Ortega Muñoz, CEO and Medical Director.
-
NewPrevention versus Therapy. The breakthrough of the current century
Massive data collection accelerated by the digitisation of healthcare, as well as artificial intelligence, is becoming an essential pillar for prevention.
-
NewBiomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma...
Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the need to promote effective mechanisms for support, funding, and collaboration to
-
Press release
Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to ma...
Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research Technology Platforms the need to promote effective mechanisms for support, funding, and collaboration to
-
CompanyMICROVIABLE THERAPEUTICS
-
NewORYZON awarded 13.26 million € through the first Important Project of Common European Inte...
Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases.
